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Routine implementation of new technologies and innovation
within standard practice is a pertinent issue within healthcare, and
one which crosses both geographical and disciplinary boundaries.1,2
The Cooksey report identified cultural, financial and institutional
barriers to the implementation of health research, with recom-
mendations suggesting translational research should be viewed as
a key area for future investment.3 Within England and Wales, policy
and treatment decisions are guided by the National Institute for
Health and Care Excellence (NICE) guideline programme.
Guidelines are typically based on evidence reviews with a focus on
efficacy and cost-effectiveness. Likewise, international approaches
to quality assurance and evaluation have also aimed to use
best available evidence to improve patient care by assisting
policy makers and clinicians with the decision-making process.4
However, implementation of interventions within routine practice
often remains low.5 For example, an audit of four adult
community mental health teams within one London trust
highlighted that only a minority of eligible patients received the
interventions recommended in the schizophrenia guideline
update.6 Recommending interventions that cannot readily be
implemented wastes resources.
Feasibility of an intervention is one important characteristic
with regard to evidence translation.7 We define feasibility as the
cumulative impact of different influences that have an effect on
the implementation of an intervention within a specific healthcare
system or practice. Across medical disciplines there is a need to
better characterise what is and is not feasible within practice to
minimise wasted resources, inform prioritisation decisions and
improve effectiveness in health systems. At present no structured
and psychometrically validated measure has been specifically
designed to assess the feasibility of complex interventions for
implementation within mental health services.8 Furthermore,
despite reporting guidelines such as the CONSORT statement
having led to demonstrable improvements in the reporting of
studies within high-quality journals,9 there are no reporting
guidelines which allow the feasibility of an intervention to be
assessed. This study aims (a) to produce an evidence-based
measure of the feasibility of implementing a complex intervention
in mental health services within the National Health Service
(NHS) and (b) to develop reporting guidelines identifying
information to report that allows feasibility to be assessed.
Method
Study design
A focused narrative review was used to inform the development of
a measure, the Structured Assessment of FEasibility (SAFE). This
was followed by psychometric evaluation and modification of
the measure through piloting. Ethical approval was obtained from
the South East London Research Ethics Committee 4 (formally
known as Joint South London & Maudsley and the Institute of
Psychiatry NHS Research Ethics Committee) approval 10/H0807/4.
Literature search
Four data sources were used to identify potential studies for
inclusion in the focused narrative review: (a) Google Scholar,
NHS evidence and PubMed were searched using the terms ‘‘imple-
mentation’’ AND (‘‘barriers’’ OR ‘‘facilitators’’) AND ‘‘mental
health’’; (b) table of contents for the journal Implementation
Science from January 1999 until December 2010; (c) hand
searching the references of retrieved papers for additional
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Background
The feasibility of implementation is insufficiently considered
in clinical guideline development, leading to human and
financial resource wastage.
Aims
To develop (a) an empirically based standardised measure of
the feasibility of complex interventions for use within mental
health services and (b) reporting guidelines to facilitate
feasibility assessment.
Method
A focused narrative review of studies assessing
implementation blocks and enablers was conducted with
thematic analysis and vote counting used to determine
candidate items for the measure. Twenty purposively
sampled studies (15 trial reports, 5 protocols) were included
in the psychometric evaluation, spanning different
interventions types. Cohen’s kappa (k) was calculated for
interrater reliability and test–retest reliability.
Results
In total, 95 influences on implementation were identified
from 299 references. The final measure – Structured
Assessment of FEasibility (SAFE) – comprises 16 items rated
on a Likert scale. There was excellent interrater (k= 0.84,
95% CI 0.79–0.89) and test–retest reliability (k= 0.89, 95% CI
0.85–0.93). Cost information and training time were the two
influences least likely to be reported in intervention papers.
The SAFE reporting guidelines include 16 items organised
into three categories (intervention, resource consequences,
evaluation).
Conclusions
A novel approach to evaluating interventions, SAFE,
supplements efficacy and health economic evidence. The
SAFE reporting guidelines will allow feasibility of an
intervention to be systematically assessed.
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citations; and (d) recommendations from an implementation
science expert.
Eligibility criteria
The review included both quantitative and qualitative papers
providing the paper presented factors linked to implementation
and met the following inclusion criteria: (a) available in print or
downloadable format (PDF file or Word document); (b) focused
on mental health or an area directly applicable to mental health
such as empowerment or shared decision-making in long-term
conditions; (c) the study was either a primary qualitative study
with ten or more participants, a quantitative or qualitative survey
or systematic review of the literature including either qualitative
or quantitative evidence; (d) primary studies were conducted
within the UK or (for review studies) a proportion of the
included studies were conducted within the UK to ensure
applicability to the NHS context; and (e) the study focused on
the implementation of a manualised intervention or guideline at
the individual staff, team or service level.
Data extraction and tabulation
For each included paper the following data were extracted and
recorded in an online database: study methodology, target
population, study location, details of the intervention or guideline
being implemented and the main implementation barriers and
facilitators identified. To assess the quality of the included studies
the RATS checklist10 was used for qualitative papers, the Effective
Public Health Practice Project tool11 was used for quantitative
research and the NICE systematic review checklist12 was used
for review studies. For qualitative studies, poor quality was
defined as two or more red flags (as indicated on the RATS
checklist). Quantitative studies or systematic reviews receiving a
negative quality rating on their respective tools were defined as
poor quality because for both types of study a negative rating
indicates significant evidence of bias within the study. Poor quality
studies were excluded.
Development of SAFE
Thematic analysis was used to identify implementation influences
– barriers and facilitators, within the included studies. These
were tabulated and vote counting used to determine the frequency
of each theme across the included papers. Influences included
in two or fewer studies were excluded as a result of limited
generalisability. The decision to include factors included in three
or more papers was a pragmatic decision to reduce the potential
number of candidate items. We took this decision to help ensure
that the items included in the measure would be generalisable
across different interventions and settings within the NHS and not
just specific to a particular study. The remaining implementation
influences were assessed to check their relevance to characterising
the feasibility of an intervention. Only influences that directly
related to characteristics of the intervention were included, such
as the amount of training required or whether the intervention
was manualised for example. Each influence was then operational-
ised as a single question, for example the implementation barrier
lack of time was operationalised as: is the intervention time
consuming? Each item was rated as ‘yes’, ‘partial’, ‘no’ or ‘unable
to rate’. Anchor points for each item were developed based on
the consensus opinion of three NHS clinicians and two researchers.
The draft measure was then piloted and modified by three
members of the research team (one clinician and two researchers)
to ensure the rating categories were comprehensively defined and
the measure easy to use.
Psychometric evaluation
Within the psychometric evaluation of SAFE, 19 purposively
selected papers (reporting on 20 interventions) were rated using
the measure (references available from the authors on request).
The interventions were described in trial reports (n= 15) and
study protocols (n= 5), and spanned pharmacotherapy (n= 2),
psychosocial (n= 12) and service-based interventions (n= 6). To
investigate test–retest reliability, each paper was re-rated 1 week
later. To investigate interrater reliability, each paper was double
rated by at least one of three other researchers. Reliability was
measured using weighted Cohen’s kappa (k). Confidence intervals
were calculated using Wilson efficient-score method, corrected
for continuity with a coefficient 40.75 representing excellent
reliability.13 Cohen’s k was calculated for overall agreement
between raters and to rate agreement by category (yes v. partial
v. no v. unable to rate).
Results
Development of the measure
A total of 299 references were identified in the literature search of
which 54 articles were potentially relevant and the full text
retrieved. Eleven papers were eligible for inclusion.7,14–23 These
comprised four systematic reviews, two narrative reviews, two
survey designs and two semi-structured interview studies and
one based on expert consensus. Of the 11 papers, 6 assessed
facilitators and barriers of implementation within the NHS and
5 reviewed the international literature, including UK-based
papers. Additionally, 43 papers were excluded. The most common
reason for exclusion was that results of the paper were not
applicable to the NHS context (online supplement DS1).
Ninety-five implementation influences (i.e. barriers and
facilitators) were identified from the 11 included papers. A total
of 39 of these 95 influences related to the characteristics of the
intervention so were retained and included in the vote counting
(online Appendix DS1).
The most common implementation themes were staff skills
required to carry out the intervention, applicability of the
intervention to the population of interest and concordance with
staff values. From the 39 influences, 18 (listed first in Appendix
DS1) were identified in at least 3 papers and were used as
candidate items for the measure. Items were then selected through
a process of consensus and consultation within the research team,
by merging items (e.g. additional skills or knowledge required
was merged with the need for additional training), separating
items (e.g. cost implications of the intervention was split into
cost-effectiveness and the cost of setting up the intervention)
and deleting one item (concerning the match with staff values,
as this could not be rated based on intervention papers alone).
This process produced a 16-item draft measure, comprising eight
barriers and eight facilitators of implementation. The measure
was piloted and modifications made to the descriptions of each
category, including defining the ‘unable to rate’ category, and
adding more detail to items 3 and 14. This resulted in the final
measure (available at www.researchintorecovery.com/our-measures).
Both the Cochrane collaboration24 and the Centre for Reviews
and Dissemination guidance25 recommend against using
summary scores on quality assessments to categorise papers
within a systematic review, since items within the scale may have
unequal weight. Instead, it is recommended that reviewers attend
to the individual items of the scale when conducting sensitivity
and subgroup analyses. This same approach was therefore adopted
for scoring SAFE, whereby the reviewer rates individual items,
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without providing an overall summary score, as barriers and
facilitators differ in their importance depending on the context.
Psychometric properties
Interrater reliability (k= 0.84, 95% CI 0.79–0.89) and test–retest
reliability (k= 0.89, 95% CI 0.85–0.93) were both excellent. Across
all responses, interrater agreement was 89% (95% CI 85–92) and
test–retest agreement was 92.5% (95% CI 89–95).
The ‘partial’ category produced the lowest percentage
agreement across different raters and time points (Table 1). Our
impression is that the lower consistency was as a result of unclear
descriptions given in the papers, rather than because of raters
switching to other responses. For example, it was often hard to
determine whether an intervention had two or three components
or whether the training involved X or Y amount of time. Table 2
provides the frequencies for each response category per item
and suggests the items varied in the proportion of each category
response. The overall level of agreement per item (irrespective of
response category, for example ‘yes’, ‘no’) was consistently very
high, ranging from 80 to 100%. Agreement between raters and
across time points was 95–100% for over half of the items.
Reporting of implementation influences
The percentage of papers reporting enough information to allow
for a rating varied for each item (Table 2). As detailed in Table
3, 90% of papers did not provide enough information for cost
saving to be rated, followed by staff training (45%) and ongoing
supervision (35%). In contrast, the complexity of the intervention,
the applicability of the population, and additional human and
material resources were rateable for all papers (i.e. 100%).
Reporting guidelines
Each item from the developed measure was modified and
reorganised to produce reporting guidelines (available at www.
researchintorecovery.com/our-measures).
Discussion
The SAFE scale was developed on the basis of a focused literature
review that identified barriers and facilitators of implementation
specifically related to characteristics of the intervention being
assessed. The resulting tool was demonstrated to be useable across
a range of studies from simple pharmacological interventions
through to complex service-level innovations, with the psycho-
metric evaluation indicating that SAFE has excellent interrater
318
Table 1 Percentage agreement for each response category
Response category Agreement, % (95% CI)
Interrater
Yes 84.5 (78.0–89.5)
Partial 57.8 (45.5–69.2)
No 87.0 (76.2–93.5)
Unable to rate 89.4 (76.1–96.0)
Test–retest
Yes 90.7 (84.9–94.6)
Partial 72.9 (60.7–82.5)
No 89.1 (78.2–95.1)
Unable to rate 85.4 (71.6–93.5)
Table 2 Number (and percentage) of papers with each response category by SAFE item
Response Q1 Q2 Q3 Q4 Q5 Q6 Q7 Q8 Q9 Q10 Q11 Q12 Q13 Q14 Q15 Q16
Yes 6 (30) 16 (80) 6 (30) 2 (10) 4 (20) 5 (25) 7 (35) 1 (5) 20 (100) 10 (50) 17 (85) 10 (50) 1 (5) 13 (65) 18 (90) 19 (95)
Partial 0 (0) 2 (10) 6 (30) 3 (15) 10 (50) 3 (15) 5 (25) 1 (5) 0 (0) 7 (35) 2 (10) 9 (45) 1 (5) 7 (35) 1 (5) 1 (5)
No 5 (25) 2 (10) 3 (15) 8 (40) 5 (25) 12 (60) 4 (20) 18 (90) 0 (0) 3 (15) 1 (5) 0 (0) 0 (0) 0 (0) 1 (5) 0 (0)
Unable to rate 9 (45) 0 (0) 5 (25) 7 (35) 1 (5) 0 (0) 4 (20) 0 (0) 0 (0) 0 (0) 0 (0) 1 (5) 18 (90) 0 (0) 0 (0) 0 (0)
Q, question; SAFE, Structured Assessment of FEasibility.
Table 3 Items able to be rated in the included papers (n = 20)
n (%)
Trial papers (n= 15) Protocol papers (n= 5) Total papers (n= 20)
13. Cost saving 2 (13) 0 (0) 2 (10)
1. Staff training 10 (67) 1 (20) 11 (55)
4. Ongoing supervision 10 (67) 3 (60) 13 (65)
3. Time consuming 13 (87) 2 (40) 15 (75)
7. Costly set up 12 (80) 4 (80) 16 (80)
5. Additional human resources 15 (100) 4 (80) 19 (95)
12. Effectiveness 14 (93) 5 (100) 19 (95)
2. Intervention complexity 15 (100) 5 (100) 20 (100)
6. Additional material resources 15 (100) 5 (100) 20 (100)
8. Adverse events 15 (100) 5 (100) 20 (100)
9. Applicable to population of interest 15 (100) 5 (100) 20 (100)
10. Manualised 15 (100) 5 (100) 20 (100)
11. Flexibility 15 (100) 5 (100) 20 (100)
14. Matches prioritised goals 15 (100) 5 (100) 20 (100)
15. Pilotable 15 (100) 5 (100) 20 (100)
16. Reversible 15 (100) 5 (100) 20 (100)
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and test–retest reliability. Across the 15 trial reports and 5 trial
protocols, frequently unreported aspects included cost
information, staff training time and ongoing support and
supervision. The SAFE reporting guidelines were developed to
identify the information needed in intervention reports that allow
SAFE to be rated. We believe that the scale will be useful for three
groups. First, for reviewers and policy makers when assessing the
evidence base for an intervention. Second, researchers developing
an intervention could make use of the scale to ensure they
consider factors related to the implementation of that inter-
vention. Finally, the reporting guidelines are intended to be used
by authors reporting an intervention.
Strengths and limitations
Although we have demonstrated that SAFE is a useable and
reliable measure, our study has a number of limitations. First, the
candidate-item selection process was not systematic. Instead we
conducted a selective but focused review of the implementation
science literature. It is possible that a wider systematic review
would have identified additional implementation barriers and
facilitators in relation to characteristics of the intervention.
Further to this, the review was restricted to mental health services
within the NHS. Although this may limit the tool’s applicability to
other healthcare settings, a number of systematic reviews have
identified similar implementation barriers and facilitators in other
settings (such as in the USA) and for other long-term health
conditions.17 Furthermore, a number of included reviews assessed
the implementation literature on a broader scale. Specifically, for a
review to be included in the thematic analysis, it needed to present
data that was applicable, but not restricted, to the UK.
A second limitation was the small-scale pilot and psycho-
metric evaluation. Twenty interventions were included in the
psychometric evaluation. These were rated by up to four different
reviewers, with one reviewer rating each paper a week later to
assess test–retest reliability. Although the number of studies was
limited, the papers included in the evaluation covered a broad
range of interventions (including many featured within NICE
clinical guidance). The focus of the psychometric evaluation
mirrored the areas important to a systematic review used for
evidence appraisal. For example, within good-quality systematic
reviews, multiple reviewers will rate included papers (interrater
reliability), with the aim of systematic reviews to be reproducible
across time (test–retest reliability). The psychometric properties
evaluated in this study were selected to reflect these features.
Future work could look at evaluating the use of SAFE within an
evidence review procedure such as a health technology appraisal
or guideline development process.
Finally, the methods used to develop the reporting guidelines
were limited in their scope. Moher and colleagues suggest a
method for developing reporting guidelines that includes a review
of the literature followed by a Delphi exercise and face-to-face
consensus meeting.26 As the reporting guidelines in this study
focus specifically on allowing the rating of SAFE within evidence
appraisal and decision-making processes, a more pragmatic
approach to the development process was undertaken, in that each
item in SAFE was constructed as an item in the reporting
guidance. Future work could look at expanding these reporting
guidelines to include other areas outside of mental health services
and implementation features in addition to the characteristics of
the intervention.
Despite these limitations, one strength of the study was that
the psychometric evaluation indicated that SAFE is useable and
reliable. The ease of use of SAFE suggests it could be easily
appended to current evidence review processes across a range of
different contexts. The associated reporting guidelines also have
the potential to have a positive impact on the quality of inter-
ventions reported in peer-reviewed journals, thus providing
systematic reviewers and policy makers with the information
needed to evaluate likely implementation.
Comparison with the literature
Over the past decade implementation science has become a
rapidly evolving area of interest with research attention turning
to the implementation and sustainability of programmes and
innovations within routine clinical care.27 Within their review of
the literature, Wiltsey Stirman and colleagues28 identified 125
studies investigating sustainability, including 20 studies within
the mental health domain. They found that innovation
characteristics including fit with current practice, ability for the
innovation to be modified and effectiveness were important
influences on the sustainability of the innovation being assessed
in the individual studies. Furthermore, features such as resources,
working culture and training and education requirements also had
an impact and match items included in the SAFE scale.
Although SAFE is a novel tool for assessing the feasibility of an
intervention at the evidence review stage, other attempts have
been made to assess and characterise the barriers to routine trans-
lation of evidence into practice. In their review of implementation
measures, Chaudoir and colleagues identified 62 available
measures assessing different aspects of implementation.8 None
of the identified measures specifically focused on the
characteristics of an intervention associated with feasibility,
instead the measures were either restricted to evaluations of
specific interventions, focused on guideline implementation or
including assessment of the innovation alongside other areas such
as staff attitudes, political context, organisation factors, all of
which would not be possible to assess at the evidence appraisal
phase. Furthermore, unlike SAFE, which has demonstrable
interrater and test–retest reliability, the majority of measures in
the review were not psychometrically evaluated.8 Although not
included in the Chaudoir et al review,8 the NHS Institute for
Innovation and Improvement has recently developed the Spread
and Adoption tool, which aims to help staff increase the
sustainable implementation of innovations within the NHS.29
This online-based tool asks individuals to rate their agreement
with a number of statements grouped into three categories:
people, innovation and context. Although providing a summary
assessment, the tool does not specifically focus on rating the
feasibility of the intervention and instead covers a broader range
of contextual factors; furthermore, it lacks a clear empirical basis.
Finally, Slaghuis and colleagues30 have also developed a framework
and instrument to measure the sustainability of new work
practices being implemented in long-term care. They identify
‘routinisation’ and ‘institutionalisation’ as the two elements of
sustainability. However, as with the measures included in the
Chaudoir et al review,8 the framework and measure are designed
to evaluate practices within clinical use, rather than at the
evidence review stage. By contrast, SAFE assesses individual
intervention papers during the policy-making process.
Relevance for practice and policy
To support implementation in clinical practice, an understanding
of the factors that facilitate or hinder successful evidence
utilisation is required. At present, healthcare improvements have
often been targeted at factors related to individual healthcare
practitioners, such as their knowledge, routine and attitudes.27,31
However, successful implementation is influenced by components
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occurring at multiple ecological levels of the healthcare system,
such as the individual, social, organisation, economic and political
context and patient beliefs and behaviour.7,32–34 Implementation
is a complex social process linked with the context in which it
takes place.
The SAFE scale specifically focuses on one factor indentified as
important to successful implementation, namely the characteristics
of the intervention. Within this complex process of implementation,
rating feasibility based on the characteristics of that intervention
offers a circumscribed and useable source of information for both
reviewers and policy makers when making decisions about
evidence recommendations. Guideline development processes
make use of systematic reviews of best available evidence as part
of the decision-making process, alongside other rating systems
such as GRADE (Grading of Recommendations Assessment,
Development and Evaluation), which makes statements about
the overall quality of the evidence. Recently, there have been
further suggestions that the GRADE process should incorporate
other features of the evidence and intervention including resource
allocation.35 It is at this stage in the evidence review process that
SAFE could be used to help clinicians and guideline panellists with
the decision-making process.
A number of papers have focused on the implementation of
NICE clinical guidelines for mental health conditions. Despite a
range of initiatives, implementation within routine care,
particularly of psychological therapies and interventions focusing
on physical healthcare, has remained low.14,36,37 For instance,
uptake of both family intervention and cognitive–behavioural
therapy (CBT) for psychosis has been low, with estimates
suggesting that less than 30% of eligible patients receive these
interventions.38 These findings are not restricted to schizophrenia
– Rhodes and colleagues39 found that although the majority of
clinicians were aware of and using NICE clinical guidance for
depression, only 20% felt confident in their use of the guidelines.
Many clinicians stated that resource implications, lack of time and
availability of training had a negative impact on their routine
utilisation within clinical practice. Using SAFE within the evidence
review process could help to highlight areas of interventions that
make their implementation more difficult. This would allow for
the strategic targeting of resources and the tailoring of imple-
mentation strategies at an early stage in the dissemination process
to overcome these issues and hence maximise routine
implementation. As well as the clinical gains, the cost savings
arising from higher levels of implementation are potentially
significant. For example, Vos and colleagues40 indicated that if
recommended treatments that are currently underutilised, such
as CBT for depression and anxiety and family interventions for
schizophrenia, were implemented then significant cost savings
would be made, in addition to improvements in the health status
of individuals.
The second aim of the paper was to produce a checklist for
authors to use when reporting interventions. The pilot study
indicated that a number of areas are at present poorly reported
in both trial protocols and in randomised controlled trial
publications. For instance, despite economic costs and staff time
constraints being identified as two main barriers to implementation,
few trial publications and protocols reported details of these areas.
One way to improve the consistency of reporting within journals
is the use of reporting guidelines. Hopewell and colleagues9 have
recently demonstrated that the implementation of CONSORT
has led to improvements in the abstracts of articles published in
a number of high-quality medical journals. Although the SAFE
reporting guidelines have not been developed using a formal
framework,26 they are empirically supported and will support
improved characterisation of feasibility.
Future research
Given the interest in implementation science and the increasing
evidence to suggest low implementation of evidence within
clinical practice, it is imperative that future work continues to
assess not only the barriers to implementation but how these
can be overcome. The results presented here represent a pilot
study and small psychometric evaluation of a new measure and
reporting guideline. Larger-scale work is needed to assess the
utility of SAFE within systematic reviews such as those used within
the guideline development process. Additionally, work could focus
on adapting and modifying SAFE so that it is applicable to other
areas of healthcare and other non-UK settings. In particular,
implementation influences may differ across settings, and the
degree of commonality is unknown – future research using the
same methodology with different clinical populations and service
settings will be needed to establish whether the same influences,
and hence SAFE, apply.
Implications
The SAFE scale represents a novel approach to assessing the
feasibility of different interventions. It has the potential to be used
alongside efficacy and health economic evidence to assist
commissioners, policy makers and guideline developers with their
decision-making processes. This comes at a time when mental
health services worldwide are faced with increasingly difficult
decisions regarding resource allocation and implementation
priorities. Furthermore, the identification of reporting guidelines
for feasibility provides a mechanism for standardising the
reporting of this aspect of interventions within high-quality
peer-reviewed publications.
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